L04AA31 • teriflunomide • Antineoplastic and immunomodulating agents | Immunosuppressants | Selective immunosuppressants
Teriflunomide is an immunomodulatory medication used for the treatment of relapsing multiple sclerosis. It works by inhibiting de novo pyrimidine synthesis, thereby reducing the activity of immune cells involved in the inflammatory process.
The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and undergo regular medical check-ups to monitor liver and hematological function.
Patients should be aware of potential side effects, such as nausea, diarrhea, or elevated liver enzymes. It is important to inform the doctor of any unusual symptoms or the use of other medications.
Common side effects include nausea, diarrhea, hair loss, and elevated liver enzymes. In rare cases, severe reactions such as hepatotoxicity or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
Substance: teriflunomide
Date of last drug list: 01-03-2023
Commercial code: W69382001
Concentration: 14mg
Pharmaceutical form: film-coated tablets
Quantity: 14
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: PHARMASCIENCE INTERNATIONAL LTD. - CIPRU
Holder: GEDEON RICHTER ROMANIA S.A. - ROMANIA
Number: 14864/2023/01
Shelf life: 3 years